TRICUSPID VALVE DISEASE
Clinical trials for TRICUSPID VALVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new TRICUSPID VALVE DISEASE trials appear
Sign up with your email to follow new studies for TRICUSPID VALVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart valve trial offers hope for tricuspid patients
Disease control Recruiting nowThis study is testing a new replacement valve for people with tricuspid heart valve disease. About 92 adults and children will receive the valve during surgery. Researchers will check if the valve is safe and works well for up to 12 months, with follow-up for 5 years.
Matched conditions: TRICUSPID VALVE DISEASE
Phase: NA • Sponsor: Corvivo Cardiovascular, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Tiny valve on a catheter aims to fix failing hearts
Disease control Recruiting nowThis is an early study to see if a new device called the DUO System is safe and works for people with a severely leaky tricuspid heart valve. Doctors will place the device using a catheter through a blood vessel, avoiding open-heart surgery. The study will follow 15 patients for …
Matched conditions: TRICUSPID VALVE DISEASE
Phase: NA • Sponsor: CroiValve Limited • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New heart valve replacement could help patients with severe leaky valve
Disease control Recruiting nowThis study is testing a new device called the VDyne System to replace the tricuspid valve in people with severe tricuspid regurgitation (a leaky heart valve). About 120 adults who have not improved with standard heart failure medications will receive the device. The goal is to se…
Matched conditions: TRICUSPID VALVE DISEASE
Phase: NA • Sponsor: VDyne, Inc. • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
New heart valve repair could help thousands avoid Open-Heart surgery
Disease control Recruiting nowThis study tests a device called the Edwards PASCAL system to repair a leaky tricuspid heart valve without open-heart surgery. About 1,270 people with severe symptoms will be randomly assigned to get the device plus standard medical care, or standard care alone. The goal is to se…
Matched conditions: TRICUSPID VALVE DISEASE
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
New heart valve device offers hope for severe leaky valve patients
Disease control Recruiting nowThis study tests a new device called the VDyne System to replace the tricuspid valve in people with severe leakage. The goal is to see if it safely reduces symptoms and improves daily life. About 30 adults with severe tricuspid regurgitation will be enrolled. The approach is a mi…
Matched conditions: TRICUSPID VALVE DISEASE
Phase: NA • Sponsor: VDyne, Inc. • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New heart valve implant trial offers hope for valve disease patients
Disease control Recruiting nowThis study is testing a new surgical implant called the CorMatrix ECM Valve to replace damaged tricuspid heart valves. Researchers want to see if the valve can be safely implanted and works well to control the disease. The trial will include up to 78 adults and children who need …
Matched conditions: TRICUSPID VALVE DISEASE
Phase: NA • Sponsor: Corvivo Cardiovascular, Inc. • Aim: Disease control
Last updated Apr 14, 2026 13:09 UTC
-
10,000 patients join heart valve watch study
Knowledge-focused Recruiting nowThis study follows 10,000 adults with heart valve disease to understand how the condition progresses and what factors influence it. Researchers will use imaging tests like echocardiograms, CT scans, and MRIs, along with medical history and lifestyle information. The goal is to pr…
Matched conditions: TRICUSPID VALVE DISEASE
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated May 17, 2026 05:05 UTC